FERRIMED 50MG/5ML SYRUP

Indications

• Nutritional supplementation
• Management of blood glucose levels in diabetes
• Energy source for athletes or individuals with increased energy demands
• Support for gut health as a prebiotic

Dosage

Children: Refer to specific product guidelines for dosing, as it may vary based on formulation and indication.

Adults: Refer to specific product guidelines for dosing, as it may vary based on formulation and indication.

Mechanism of action

Polymaltose is metabolized into glucose, which serves as a source of energy for the body. It is characterized by its slow digestion and absorption, which helps maintain steady blood glucose levels. The slow-release characteristic is attributed to its polysaccharide structure, which requires enzymatic breakdown in the gastrointestinal tract before absorption occurs.

Pharmacodynamics

The pharmacodynamics of polymaltose involve its role in providing a sustained release of glucose into the bloodstream, which can prevent spikes in blood sugar levels. This gradual release is particularly advantageous in managing energy levels for individuals with diabetes or those needing controlled carbohydrate intake. Additionally, polymaltose may exhibit prebiotic effects, enhancing the growth of beneficial intestinal microbiota, thus contributing to improved gastrointestinal health.

Pharmacokinetics

Polymaltose is not directly absorbed in the gastrointestinal tract due to its complex structure. Instead, it undergoes enzymatic hydrolysis primarily in the small intestine, where it is broken down into glucose units. The absorption of these glucose units occurs through the intestinal mucosa into the bloodstream. The rate of absorption is slower compared to simple sugars, resulting in a gradual increase in blood glucose levels. The elimination of glucose from the bloodstream is mediated by insulin, which facilitates its uptake by tissues for energy production.

Adverse effects

• Gastrointestinal discomfort
• Nausea
• Diarrhea
• Allergic reactions (rare)

Precautions

• Use with caution in patients with diabetes mellitus due to potential carbohydrate content
• Monitor for gastrointestinal side effects, especially in patients with pre-existing gastrointestinal disorders

Pregnancy

Polymaltose is generally considered safe during pregnancy, but medical advice should be sought before use.

Breast-feeding

Polymaltose is likely safe during breastfeeding, but it is advisable to consult with a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral syrup
• Oral solution
• Granules

Indications

• Influenza prevention
• Diphtheria prevention
• Tetanus prevention
• Pertussis prevention

Dosage

Children: Refer to specific vaccine guidelines for paediatric dosing, as it varies by vaccine type and indication.

Adults: Refer to specific vaccine guidelines for adult dosing, as it varies by vaccine type and indication.

Mechanism of action

Trivalent vaccines function by introducing inactivated or attenuated forms of three different strains of a pathogen into the body, stimulating an immune response. This process activates B-cells to produce antibodies specific to the strains present in the vaccine. The immune system then remembers these strains, enabling a quicker and more effective response upon future exposure.

Pharmacodynamics

The pharmacodynamics of trivalent vaccines involve the induction of both humoral and cellular immunity. Upon vaccination, the immune system generates antibodies against the three strains, leading to neutralization of the pathogens. Additionally, T-helper cells are activated, promoting the proliferation of B-cells and the formation of memory cells, which provide long-term immunity.

Pharmacokinetics

Trivalent vaccines have a unique pharmacokinetic profile as they are not absorbed or distributed like traditional pharmacological agents. Instead, they are administered via injection, leading to localized immune activation. The onset of immune response typically occurs within two weeks post-vaccination, with peak antibody levels reached within one to two months. The duration of immunity can vary, requiring booster doses for sustained protection.

Adverse effects

• Injection site reactions
• Fever
• Malaise
• Fatigue
• Headache
• Myalgia
• Nausea

Precautions

• Use with caution in individuals with a history of allergic reactions to vaccine components
• Monitor for allergic reactions post-vaccination
• Consider underlying conditions that may affect immune response

Pregnancy

Generally considered safe, but consult healthcare provider for individual assessment.

Breast-feeding

Typically safe, but consult healthcare provider for individual assessment.

Storage

Store in a refrigerator at 2-8 degrees Celsius, do not freeze.

Formulations

• Trivalent inactivated influenza vaccine
• Trivalent live attenuated influenza vaccine